Biopsy, Bladder
Bladder biopsy is a procedure in which a sample of urinary bladder tissue to obtained for histopathologic examination. The indications for bladder biopsy include a variety of neoplastic and non-neoplastic conditions requiring pathologic confirmation such as urinary bladder papilloma, cystitis, urothelial dysplasia, urothelial carcinoma, adenocarcinoma, and rarely metastatic tumors. The procedure is also often performed to assess the depth of invasion for bladder carcinoma which is important for staging, prognosis, and planning the treatment.
Bladder biopsy is most commonly performed via transurethral approach (cystoscopic biopsy), although image-guided percutaneous biopsy (under CT or ultrasound guidance) is technically feasible and indicated in certain clinical conditions such as urethral strictures and tumors in the ‘cytoscopic blind spots’. Both approaches can be performed as an outpatient procedure requiring minimal anesthesia. The procedure is generally safe; potential complications include urinary tract infection, extraperitoneal or intraperitoneal hemorrhage, urinoma, tumor seeding along the biopsy tract (with percutaneous biopsy) and bladder wall rupture.
- Evaluation of intractable cystitis
- Diagnosis and staging of urothelial neoplasms
- Evaluation of intramural mass lesions
There are no universal reference ranges for bladder biopsies. In general, bladder biopsies consist of benign urothelial mucosa and submucosal connective tissue.
Biopsies are obtained by a urologist (cystoscopic biopsies) or an interventional radiologist (percutaneous biopsies) under ultrasound or CT guidance. Routine specimens are placed directly in formalin fixative and sent to histopathologic examination. When culture is indicated (suspected infectious causes), the specimen is placed in a sterile container for microbiologic assessment.
- Tech Vasc Interv Radiol. 2016 Sep;19(3):237-44 [PMID: 27641458]
- Abdom Imaging. 2015 Aug;40(6):1838-42 [PMID: 2587586]
- Eur Urol. 2013 Feb;63(2):321-32. [PMID: 23088996]
- Transl Androl Urol. 2017 Dec;6(6):1090-1110. [PMID: 29354496]
- J Natl Compr Canc Netw. 2017 Oct;15(10):1268-1274. [PMID: 28982751]